The landscape of dementia analysis has developed drastically with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology years ahead of indications emerge. Whilst these technological improvements stand for outstanding progress in knowledge neurodegenerative